A detailed history of Callan Capital, LLC transactions in Equillium, Inc. stock. As of the latest transaction made, Callan Capital, LLC holds 99,688 shares of EQ stock, worth $60,809. This represents 0.01% of its overall portfolio holdings.

Number of Shares
99,688
Previous 99,688 -0.0%
Holding current value
$60,809
Previous $68,000 20.59%
% of portfolio
0.01%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 02, 2024

SELL
$0.48 - $0.74 $1,920 - $2,960
-4,000 Reduced 3.86%
99,688 $71,000
Q4 2022

Feb 13, 2023

BUY
$0.83 - $2.26 $86,061 - $234,334
103,688 New
103,688 $109,000

Others Institutions Holding EQ

About Equillium, Inc.


  • Ticker EQ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 34,352,100
  • Market Cap $21M
  • Description
  • Equillium, Inc., a clinical-stage biotechnology company, develops and sells products to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need. The company's lead product candidate is itolizumab (EQ001), a clinical-stage monoclonal antibody that targets the novel immune checkpoint receptor CD6, which i...
More about EQ
Track This Portfolio

Track Callan Capital, LLC Portfolio

Follow Callan Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Callan Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Callan Capital, LLC with notifications on news.